Summit X, LLC Palatin Technologies Inc Transaction History

Summit X, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$0.37 - $0.54 $12,950 - $18,900	-35,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$0.36 - $0.79 $900 - $1,975	2,500 Added 7.69%	35,000 $15,000
Q4 2019 Jan 23, 2020	BUY	$0.75 - $0.89 $1,875 - $2,225	2,500 Added 8.33%	32,500 $25,000
Q3 2019 Oct 15, 2019	BUY	$0.78 - $1.09 $11,700 - $16,350	15,000 Added 100.0%	30,000 $27,000
Q2 2019 Aug 13, 2019	BUY	$0.98 - $1.64 $14,700 - $24,600	15,000 New	15,000 $23,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.01M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.